Women's Health
What Happens to Prolactin Levels with PCOS?
Up to 30% of women with PCOS have elevated prolactin — yet it's rarely the first marker clinicians check. High prolactin can mimic, worsen, or mask other PCOS-related hormone imbalances, making it a surprisingly consequential number to understand. Here's what the research actually shows.

What Happens to Prolactin Levels with PCOS?
Prolactin is mildly to moderately elevated in roughly 20–30% of women with PCOS, though it rarely reaches the very high levels seen in pituitary adenomas. The main caveat is that elevated prolactin in PCOS is often secondary — driven by high estrogen, chronic stress, or disrupted dopamine signaling — rather than a primary pituitary disease. Women with extremely high prolactin (above 100 ng/mL) should be evaluated for a separate condition.
---
Why Prolactin Is Often Elevated in PCOS
Prolactin is a peptide hormone produced by the anterior pituitary gland. Its primary role is stimulating milk production, but it also plays a regulatory role in the menstrual cycle, ovarian function, and immune response. In women without PCOS, prolactin typically stays below 25 ng/mL outside of pregnancy and breastfeeding.
In PCOS, several overlapping mechanisms can push prolactin above that threshold:
Elevated estrogen: In PCOS, disordered follicle development leads to persistently elevated estradiol — and estrogen directly stimulates pituitary lactotroph cells to release more prolactin. This creates a feedback loop that can keep prolactin chronically elevated even without a pituitary tumor. (For a deeper look at estrogen dynamics, see what happens to estradiol levels in PCOS.)
Dopamine dysregulation: Prolactin release is normally held in check by dopamine from the hypothalamus. Several studies suggest that hypothalamic dopamine tone is altered in PCOS, meaning the brake on prolactin secretion is less effective (Barber et al., Clinical Endocrinology 2006; PMID: 16430722).
Chronic stress and cortisol: Stress elevates cortisol, which can suppress dopamine and raise prolactin indirectly. Women with PCOS already tend to have dysregulated cortisol responses — making this pathway clinically relevant. (See what happens to cortisol in PCOS for more on the HPA axis in this condition.)
Hyperinsulinemia: Elevated insulin — present in the majority of women with PCOS — appears to stimulate prolactin secretion independently of estrogen, possibly through insulin receptors on pituitary cells (Lanzone et al., Fertility and Sterility 1995; PMID: 7720088).
The result is a mildly elevated prolactin (typically 25–80 ng/mL in PCOS) that doesn't usually point to a pituitary tumor but still disrupts the hormonal environment meaningfully.
---
What Elevated Prolactin Actually Does to Your Hormones
Even mildly elevated prolactin has measurable downstream consequences in PCOS:
Suppresses GnRH and LH pulses: Prolactin acts at the hypothalamus to reduce the frequency of gonadotropin-releasing hormone (GnRH) pulses, which in turn reduces LH secretion from the pituitary. This can further disrupt the LH:FSH ratio — already abnormal in PCOS — making ovulation even less likely. (To understand how LH is already disrupted in PCOS, see what happens to LH levels when you have PCOS.)
Impairs progesterone synthesis: Chronically elevated prolactin can inhibit granulosa cell function, reducing progesterone output after ovulation. This worsens the luteal phase defects that are common in PCOS and contributes to irregular or absent periods.
Lowers SHBG: Prolactin excess can reduce sex hormone-binding globulin, which means more free testosterone is available in circulation. This compounds the hyperandrogenism that is one of the defining features of PCOS — acne, hirsutism, and hair thinning can worsen as a result. (Related: what happens to SHBG levels in PCOS.)
Affects insulin sensitivity: There is evidence that hyperprolactinemia impairs insulin signaling in peripheral tissues, potentially worsening the insulin resistance that already characterizes most PCOS phenotypes (Balbach et al., Journal of Clinical Endocrinology & Metabolism 2013; PMID: 23625955).
| Prolactin Level | Interpretation in PCOS Context |
|---|---|
| < 25 ng/mL | Normal; unlikely to be contributing to symptoms |
| 25–50 ng/mL | Mildly elevated; common in PCOS; investigate drivers |
| 50–100 ng/mL | Moderate elevation; rule out medication effects and macroprolactin |
| > 100 ng/mL | Requires pituitary imaging to rule out prolactinoma |
---
Prolactin and Sleep: The Often-Overlooked Connection
Prolactin follows a strong circadian rhythm. It peaks during sleep — particularly in the early morning hours — and drops to its nadir in the afternoon. This isn't incidental: prolactin is intimately tied to slow-wave and REM sleep, and disruptions in sleep architecture both lower and are worsened by abnormal prolactin patterns.
Women with PCOS have significantly higher rates of sleep disorders, including obstructive sleep apnea and insomnia (Helvaci et al., Gynecological Endocrinology 2012; PMID: 22129103). Disrupted sleep can blunt the normal nocturnal prolactin surge, which interferes with pituitary calibration and immune function. At the same time, chronically elevated basal prolactin during waking hours (a sign of pituitary dysregulation) is associated with poorer sleep quality in observational data.
This bidirectional relationship matters clinically. If your prolactin is elevated and you're sleeping poorly, addressing sleep quality isn't just a general wellness recommendation — it may directly influence how the pituitary regulates this hormone.
Practical steps that support healthy prolactin circadian rhythm include:
- Consistent sleep and wake times to anchor the circadian clock
- Limiting blue light exposure after 9 PM to preserve melatonin signaling
- Managing evening cortisol with stress-reduction practices
- Addressing sleep-disordered breathing if suspected (a formal sleep study is warranted in symptomatic women with PCOS)
---
Prolactin Replacement Therapy: What It Is and When It's Relevant
The phrase "prolactin replacement therapy" is occasionally searched by women who have been told their prolactin is low — and this is worth clarifying directly. There is currently no approved prolactin replacement therapy for low prolactin (hypo-prolactinemia) in clinical practice. Unlike thyroid hormones or estrogen, prolactin is not replaced pharmacologically outside of the research setting.
Conversely, treatment for high prolactin is well established. When hyperprolactinemia is confirmed as a primary driver of menstrual dysfunction or infertility, dopamine agonists — most commonly cabergoline — are prescribed to lower prolactin by directly stimulating dopamine D2 receptors on lactotroph cells. These medications are highly effective and are sometimes used in PCOS when prolactin is meaningfully elevated and contributing to anovulation.
Importantly, not every woman with PCOS and slightly elevated prolactin needs pharmacological treatment. If the elevation is mild and driven by reversible factors — high estrogen, stress, poor sleep, certain medications like antidepressants or antipsychotics — addressing those upstream drivers may bring prolactin into range without a prescription.
---
Best Supplements for Prolactin in PCOS
The supplement landscape around prolactin is narrower than for many hormones. Most research focuses on reducing elevated prolactin rather than raising it. Here is what the clinical evidence currently supports:
Vitex agnus-castus (Chasteberry): The most studied botanical for hyperprolactinemia. Vitex acts as a partial dopamine agonist — binding D2 receptors in the pituitary and reducing prolactin secretion. A systematic review of 12 trials found it significantly reduced prolactin compared to placebo in women with mild to moderate elevations (van Die et al., Journal of Alternative and Complementary Medicine 2013; PMID: 23136064). It is not appropriate for women with very high prolactin from a pituitary adenoma.
Vitamin B6 (Pyridoxine): B6 is a cofactor in dopamine synthesis. Low B6 status can impair dopamine production, potentially reducing the hypothalamic brake on prolactin. Supplementation at 200–300 mg/day has been shown to modestly lower prolactin in some studies, though this dose range carries peripheral neuropathy risk with long-term use — clinical supervision is advised.
Magnesium: Magnesium deficiency is common in PCOS and is associated with higher stress reactivity and elevated cortisol, which indirectly drives prolactin. Replenishing magnesium through well-absorbed forms supports HPA axis regulation, which is relevant to the stress-prolactin connection.
Zinc: Zinc has documented roles in dopamine receptor signaling and has been studied in PCOS for its effects on androgens and insulin. Its specific impact on prolactin is less direct, but zinc deficiency impairs overall neuroendocrine signaling in ways that may affect prolactin regulation.
Supplements to Increase Prolactin: When Would You Even Want To?
The searches around supplements to increase prolactin typically come from women who are postpartum and concerned about milk supply. In that context, galactagogues — herbs like fenugreek and blessed thistle — are used, though evidence is mixed and they are outside the PCOS conversation. In women with PCOS who are not breastfeeding, seeking to raise prolactin is almost never a clinical goal.
---
What This Means for Your Formula
Ones takes a systems-level approach to PCOS-related hormonal imbalances rather than targeting prolactin in isolation. After analyzing your blood work and health history, the AI evaluates the most probable upstream drivers — stress load, cortisol rhythm, nutrient gaps, and metabolic function — and builds a formula calibrated to those findings.
For women with PCOS where elevated prolactin appears driven by stress and cortisol dysregulation, Ones may include:
- Ashwagandha (KSM-66, 600 mg): Clinically validated at this exact dose to reduce cortisol by up to 27.9% in a randomized controlled trial (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Since cortisol dysregulation is a key upstream driver of secondary hyperprolactinemia in PCOS, reducing the stress burden matters.
- Magnesium Glycinate (as part of Ones' Magnesium Complex): Magnesium supports dopamine synthesis pathways and blunts the HPA axis response to stress. Women with PCOS are significantly more likely to be magnesium deficient, and correcting this gap supports the entire neuroendocrine environment that regulates prolactin.
- Zinc: Ones includes zinc at clinically relevant doses. Beyond its anti-androgenic effects well-documented in PCOS research, zinc's role in dopamine receptor signaling makes it relevant to the prolactin pathway as well.
Ones does not include Vitex or high-dose B6, so women whose prolactin elevation is primarily pituitary-driven would need to discuss those options with their clinician separately. What Ones does is address the metabolic and stress-related foundations that make prolactin management possible in the first place.
---
Key Takeaways
- Prolactin is mildly elevated in approximately 20–30% of women with PCOS, typically in the 25–80 ng/mL range, and is driven by estrogen excess, dopamine dysregulation, cortisol, and hyperinsulinemia rather than a primary pituitary problem.
- Even mild hyperprolactinemia disrupts LH pulsatility, impairs progesterone synthesis, lowers SHBG, and worsens insulin resistance — all of which compound existing PCOS pathology.
- Prolactin follows a strong sleep-linked circadian rhythm; poor sleep quality in PCOS both reflects and worsens abnormal prolactin patterns.
- There is no approved prolactin replacement therapy for low prolactin; treatment for high prolactin includes dopamine agonists (cabergoline) when clinically indicated.
- Vitex agnus-castus is the best-studied botanical for mildly elevated prolactin, acting as a partial dopamine agonist at the pituitary; high-dose B6 and magnesium play supporting roles via dopamine synthesis and HPA axis regulation.
- Women with prolactin above 100 ng/mL should receive pituitary imaging before attributing the elevation to PCOS; a healthcare provider should guide all treatment decisions.